Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Sanofi Sa (SNY)

Sanofi CEO Paul Hudson To Exit On Feb.17, 2026; Belén Garijo, CEO Of Merck KGaA, Named Successor 2/12/2026 3:09:37 AM

Sanofi CEO Paul Hudson To Depart; Belén Garijo Named Successor 2/12/2026 2:09:11 AM

Sanofi Appoints Belén Garijo As CEO To Succeed Paul Hudson In April 2026 2/12/2026 1:50:04 AM

Sanofi: Belén Garijo To Become CEO 2/12/2026 1:49:02 AM

Sanofi Closes Acquisition Of Dynavax 2/10/2026 9:07:20 AM

Sanofi's Rilzabrutinib Gets Breakthrough Therapy Designation In US And Orphan Drug In Japan Of WAIHA 2/9/2026 4:48:26 AM

Weekly Buzz: ATYR To Meet With FDA, SGMO Aces Fabry Study, AQST's Anaphylm Gets Rejected 2/6/2026 9:16:03 AM

Sanofi Signs Mandate For EUR 1 Bln Share Buyback 2/3/2026 1:30:04 AM

Sanofi Announces Signing Of A Share Buyback Mandate For Up To €1 Bln 2/3/2026 1:15:15 AM

Sanofi's Venglustat Hits Main Goal In Gaucher Study, Falls Short In Fabry Disease 2/2/2026 5:41:35 AM

Sanofi: Venglustat Meets All Primary Endpoints In Phase 3 Study Of Type 3 Gaucher Disease 2/2/2026 1:30:00 AM

Sanofi : Venglustat Meets All Main Goals In Phase 3 Study Of Type 3 Gaucher Disease 2/2/2026 1:05:37 AM

Sanofi Announces Positive CHMP Opinion For Rezurock In EU 1/30/2026 7:56:05 AM

Sanofi's Rezurock Recommended For EU Approval To Treat Chronic Graft-vs-host Disease 1/30/2026 7:15:32 AM

Sanofi Posts Q4 Loss, Sees Continued Profitable Growth In FY26; Plans EUR 1 Bln Buyback 1/29/2026 2:28:18 AM

Sanofi Q4 Business EPS EUR 1.53; IFRS Loss Per Share EUR 0.66 1/29/2026 1:32:05 AM

Sanofi Says SHORE, COAST-2 Phase 3 Trials Of Amlitelimab In Atopic Dermatitis Meet Key Endpoints 1/23/2026 1:57:34 AM

Sanofi’s Amlitelimab Delivers Robust Phase 3 Results In Atopic Dermatitis 1/23/2026 1:07:39 AM

- « Previous
- 1
- 2
- 3
Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap